Comparison of 27-gauge beveled-tip and 25-gauge flat-tip microincision vitrectomy surgery in the treatment of proliferative diabetic retinopathy: a randomized controlled trial

Abstract Purpose To compare the effectiveness and safety of a 27-gauge (27G) beveled-tip microincision vitrectomy surgery (MIVS) with a 25-gauge (25G) flat-tip MIVS for the treatment of proliferative diabetic retinopathy (PDR). Methods A prospective, single-masked, randomized, controlled clinical tr...

Full description

Bibliographic Details
Main Authors: Jingjie Liu, Boshi Liu, Juping Liu, Dejia Wen, Manqiao Wang, Yan Shao, Xiaorong Li
Format: Article
Language:English
Published: BMC 2023-12-01
Series:BMC Ophthalmology
Subjects:
Online Access:https://doi.org/10.1186/s12886-023-03251-2
_version_ 1797388464317005824
author Jingjie Liu
Boshi Liu
Juping Liu
Dejia Wen
Manqiao Wang
Yan Shao
Xiaorong Li
author_facet Jingjie Liu
Boshi Liu
Juping Liu
Dejia Wen
Manqiao Wang
Yan Shao
Xiaorong Li
author_sort Jingjie Liu
collection DOAJ
description Abstract Purpose To compare the effectiveness and safety of a 27-gauge (27G) beveled-tip microincision vitrectomy surgery (MIVS) with a 25-gauge (25G) flat-tip MIVS for the treatment of proliferative diabetic retinopathy (PDR). Methods A prospective, single-masked, randomized, controlled clinical trial included 52 eyes (52 patients) with PDR requiring proliferative membrane removal. They were randomly assigned in a 1:1 ratio to undergo the 27G beveled-tip and or 25G flat-tip MIVS (the 27G group and the 25G group, respectively). During surgery, the productivity of cutting the membrane, the number of vitrectomy probe (VP) exchanges to microforceps, total operation time, vitrectomy time and intraoperative complications were measured. Best-corrected visual acuity (BCVA), intraocular pressure (IOP) and postoperative complications were also assessed to month 6. Results Forty-seven eyes (47 patients) completed the follow-up, including 25 in the 27G group and 22 in the 25G group. During surgery in the 27G group, cutting the membrane was more efficient (P = 0.001), and the number of VP exchanges to microforceps was lower (P = 0.026). The occurrences of intraoperative hemorrhages and electrocoagulation also decreased significantly (P = 0.004 and P = 0.022). There were no statistical differences in the total operation time or vitrectomy time between the two groups (P = 0.275 and P = 0.372), but the former was slightly lower in the 27G group. Additionally, the 27G group required fewer wound sutures (P = 0.044). All the follow-up results revealed no significant difference between the two groups. Conclusions Compared with the 25G flat-tip MIVS, the 27G beveled-tip MIVS could be more efficient in removing the proliferative membrane while reducing the occurrence of intraoperative hemorrhages and electrocoagulation using appropriate surgical techniques and instrument parameters. Its vitreous removal performance was not inferior to that of the 25G MIVS and might offer potential advantages in total operation time. In terms of patient outcomes, advanced MIVS demonstrates equal effectiveness and safety to 25G flat-tip MIVS. Trial registration The clinical trial has been registered at Clinicaltrials.gov (NCT0544694) on 07/07/2022. And all patients in the article were enrolled after registration.
first_indexed 2024-03-08T22:40:14Z
format Article
id doaj.art-42a05711a4ba49d498f07cb3af9880fd
institution Directory Open Access Journal
issn 1471-2415
language English
last_indexed 2024-03-08T22:40:14Z
publishDate 2023-12-01
publisher BMC
record_format Article
series BMC Ophthalmology
spelling doaj.art-42a05711a4ba49d498f07cb3af9880fd2023-12-17T12:10:32ZengBMCBMC Ophthalmology1471-24152023-12-012311910.1186/s12886-023-03251-2Comparison of 27-gauge beveled-tip and 25-gauge flat-tip microincision vitrectomy surgery in the treatment of proliferative diabetic retinopathy: a randomized controlled trialJingjie Liu0Boshi Liu1Juping Liu2Dejia Wen3Manqiao Wang4Yan Shao5Xiaorong Li6Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of the National Clinical Research Center for Ocular Disease, Eye Institute, School of Optometry, Tianjin Medical University Eye HospitalTianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of the National Clinical Research Center for Ocular Disease, Eye Institute, School of Optometry, Tianjin Medical University Eye HospitalTianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of the National Clinical Research Center for Ocular Disease, Eye Institute, School of Optometry, Tianjin Medical University Eye HospitalTianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of the National Clinical Research Center for Ocular Disease, Eye Institute, School of Optometry, Tianjin Medical University Eye HospitalTianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of the National Clinical Research Center for Ocular Disease, Eye Institute, School of Optometry, Tianjin Medical University Eye HospitalTianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of the National Clinical Research Center for Ocular Disease, Eye Institute, School of Optometry, Tianjin Medical University Eye HospitalTianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of the National Clinical Research Center for Ocular Disease, Eye Institute, School of Optometry, Tianjin Medical University Eye HospitalAbstract Purpose To compare the effectiveness and safety of a 27-gauge (27G) beveled-tip microincision vitrectomy surgery (MIVS) with a 25-gauge (25G) flat-tip MIVS for the treatment of proliferative diabetic retinopathy (PDR). Methods A prospective, single-masked, randomized, controlled clinical trial included 52 eyes (52 patients) with PDR requiring proliferative membrane removal. They were randomly assigned in a 1:1 ratio to undergo the 27G beveled-tip and or 25G flat-tip MIVS (the 27G group and the 25G group, respectively). During surgery, the productivity of cutting the membrane, the number of vitrectomy probe (VP) exchanges to microforceps, total operation time, vitrectomy time and intraoperative complications were measured. Best-corrected visual acuity (BCVA), intraocular pressure (IOP) and postoperative complications were also assessed to month 6. Results Forty-seven eyes (47 patients) completed the follow-up, including 25 in the 27G group and 22 in the 25G group. During surgery in the 27G group, cutting the membrane was more efficient (P = 0.001), and the number of VP exchanges to microforceps was lower (P = 0.026). The occurrences of intraoperative hemorrhages and electrocoagulation also decreased significantly (P = 0.004 and P = 0.022). There were no statistical differences in the total operation time or vitrectomy time between the two groups (P = 0.275 and P = 0.372), but the former was slightly lower in the 27G group. Additionally, the 27G group required fewer wound sutures (P = 0.044). All the follow-up results revealed no significant difference between the two groups. Conclusions Compared with the 25G flat-tip MIVS, the 27G beveled-tip MIVS could be more efficient in removing the proliferative membrane while reducing the occurrence of intraoperative hemorrhages and electrocoagulation using appropriate surgical techniques and instrument parameters. Its vitreous removal performance was not inferior to that of the 25G MIVS and might offer potential advantages in total operation time. In terms of patient outcomes, advanced MIVS demonstrates equal effectiveness and safety to 25G flat-tip MIVS. Trial registration The clinical trial has been registered at Clinicaltrials.gov (NCT0544694) on 07/07/2022. And all patients in the article were enrolled after registration.https://doi.org/10.1186/s12886-023-03251-2VitrectomyDiabetic retinopathyVitreoretinal Surgery
spellingShingle Jingjie Liu
Boshi Liu
Juping Liu
Dejia Wen
Manqiao Wang
Yan Shao
Xiaorong Li
Comparison of 27-gauge beveled-tip and 25-gauge flat-tip microincision vitrectomy surgery in the treatment of proliferative diabetic retinopathy: a randomized controlled trial
BMC Ophthalmology
Vitrectomy
Diabetic retinopathy
Vitreoretinal Surgery
title Comparison of 27-gauge beveled-tip and 25-gauge flat-tip microincision vitrectomy surgery in the treatment of proliferative diabetic retinopathy: a randomized controlled trial
title_full Comparison of 27-gauge beveled-tip and 25-gauge flat-tip microincision vitrectomy surgery in the treatment of proliferative diabetic retinopathy: a randomized controlled trial
title_fullStr Comparison of 27-gauge beveled-tip and 25-gauge flat-tip microincision vitrectomy surgery in the treatment of proliferative diabetic retinopathy: a randomized controlled trial
title_full_unstemmed Comparison of 27-gauge beveled-tip and 25-gauge flat-tip microincision vitrectomy surgery in the treatment of proliferative diabetic retinopathy: a randomized controlled trial
title_short Comparison of 27-gauge beveled-tip and 25-gauge flat-tip microincision vitrectomy surgery in the treatment of proliferative diabetic retinopathy: a randomized controlled trial
title_sort comparison of 27 gauge beveled tip and 25 gauge flat tip microincision vitrectomy surgery in the treatment of proliferative diabetic retinopathy a randomized controlled trial
topic Vitrectomy
Diabetic retinopathy
Vitreoretinal Surgery
url https://doi.org/10.1186/s12886-023-03251-2
work_keys_str_mv AT jingjieliu comparisonof27gaugebeveledtipand25gaugeflattipmicroincisionvitrectomysurgeryinthetreatmentofproliferativediabeticretinopathyarandomizedcontrolledtrial
AT boshiliu comparisonof27gaugebeveledtipand25gaugeflattipmicroincisionvitrectomysurgeryinthetreatmentofproliferativediabeticretinopathyarandomizedcontrolledtrial
AT jupingliu comparisonof27gaugebeveledtipand25gaugeflattipmicroincisionvitrectomysurgeryinthetreatmentofproliferativediabeticretinopathyarandomizedcontrolledtrial
AT dejiawen comparisonof27gaugebeveledtipand25gaugeflattipmicroincisionvitrectomysurgeryinthetreatmentofproliferativediabeticretinopathyarandomizedcontrolledtrial
AT manqiaowang comparisonof27gaugebeveledtipand25gaugeflattipmicroincisionvitrectomysurgeryinthetreatmentofproliferativediabeticretinopathyarandomizedcontrolledtrial
AT yanshao comparisonof27gaugebeveledtipand25gaugeflattipmicroincisionvitrectomysurgeryinthetreatmentofproliferativediabeticretinopathyarandomizedcontrolledtrial
AT xiaorongli comparisonof27gaugebeveledtipand25gaugeflattipmicroincisionvitrectomysurgeryinthetreatmentofproliferativediabeticretinopathyarandomizedcontrolledtrial